1. 内閣府 令和元年度高齢社会白書
2. Niccoli, T. & L. Partridge Ageing as a risk factor for disease. Curr Biol, 22, R741- 52, 2012.
3. Tchkonia, T., Y. Zhu, J. van Deursen, J. Campisi & J. L. Kirkland Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest, 123, 966-72, 2013.
4. Hayflick, L. & P. S. Moorhead The serial cultivation of human diploid cell strains. Exp Cell Res, 25, 585-621, 1961.
5. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacocke & J. Campisi A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A, 92, 9363-7, 1995.
6. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner & W. E. Wright Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-52, 1998.
7. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach & S. W. Lowe Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88, 593-602, 1997.
8. Di Micco, R., M. Fumagalli, A. Cicalese, S. Piccinin, P. Gasparini, C. Luise, C. Schurra, M. Garre, P. G. Nuciforo, A. Bensimon, R. Maestro, P. G. Pelicci & F. d'Adda di Fagagna Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 444, 638-42, 2006.
9. Campisi, J. & F. d'Adda di Fagagna Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol, 8, 729-40, 2007.
10. Yamakoshi, K., A. Takahashi, F. Hirota, R. Nakayama, N. Ishimaru, Y. Kubo, D. J. Mann, M. Ohmura, A. Hirao, H. Saya, S. Arase, Y. Hayashi, K. Nakao, M. Matsumoto, N. Ohtani & E. Hara Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J Cell Biol, 186, 393-407, 2009.
11. Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell, 120, 513-22, 2005.
12. Mooi, W. J. & D. S. Peeper Oncogene-induced cell senescence--halting on the road to cancer. N Engl J Med, 355, 1037-46, 2006.
13. Baker, D. J., T. Wijshake, T. Tchkonia, N. K. LeBrasseur, B. G. Childs, B. van de Sluis, J. L. Kirkland & J. M. van Deursen Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature, 479, 232-6, 2011.
14. Baker, D. J., B. G. Childs, M. Durik, M. E. Wijers, C. J. Sieben, J. Zhong, R. A. Saltness, K. B. Jeganathan, G. C. Verzosa, A. Pezeshki, K. Khazaie, J. D. Miller & J. M. van Deursen Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature, 530, 184-9 2016.
15. Rodier, F., J. P. Coppe, C. K. Patil, W. A. Hoeijmakers, D. P. Munoz, S. R. Raza, A. Freund, E. Campeau, A. R. Davalos & J. Campisi Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol, 11, 973-9, 2009.
16. Demaria, M., N. Ohtani, S. A. Youssef, F. Rodier, W. Toussaint, J. R. Mitchell, R. M. Laberge, J. Vijg, H. Van Steeg, M. E. Dolle, J. H. Hoeijmakers, A. de Bruin, E. Hara & J. Campisi An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell, 31, 722-33, 2014.
17. Coppe, J. P., C. K. Patil, F. Rodier, Y. Sun, D. P. Munoz, J. Goldstein, P. S. Nelson, P. Y. Desprez & J. Campisi Senescence-associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol, 6, 2853-68, 2008.
18. Liu, D. & P. J. Hornsby Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res, 67, 3117-26, 2007.
19. Yoshimoto, S., T. M. Loo, K. Atarashi, H. Kanda, S. Sato, S. Oyadomari, Y. Iwakura, K. Oshima, H. Morita, M. Hattori, K. Honda, Y. Ishikawa, E. Hara & N. Ohtani Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, 499, 97-101, 2013.
20. Minamino, T., M. Orimo, I. Shimizu, T. Kunieda, M. Yokoyama, T. Ito, A. Nojima, A. Nabetani, Y. Oike, H. Matsubara, F. Ishikawa & I. Komuro A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med, 15, 1082-7, 2009.
21. Ferrucci, L. & E. Fabbri Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol, 15, 505-522, 2018.
22. Schneider, W. M., M. D. Chevillotte & C. M. Rice Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol, 32, 513-45, 2014.
23. Stark, G. R. & J. E. Darnell, Jr. The JAK-STAT pathway at twenty. Immunity, 36, 503-14, 2012.
24. Kiu, H. & S. E. Nicholson Biology and significance of the JAK/STAT signalling pathways. Growth Factors, 30, 88-106, 2012.
25. Cheon, H., E. G. Holvey-Bates, J. W. Schoggins, S. Forster, P. Hertzog, N. Imanaka, C. M. Rice, M. W. Jackson, D. J. Junk & G. R. Stark IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. Embo j, 32, 2751-63, 2013.
26. Wang, W., Y. Yin, L. Xu, J. Su, F. Huang, Y. Wang, P. P. C. Boor, K. Chen, W. Cao, X. Zhou, P. Liu, L. J. W. van der Laan, J. Kwekkeboom, M. P. Peppelenbosch & Q. Pan Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. Sci Signal, 10, 2017.
27. Zurney, J., K. E. Howard & B. Sherry Basal expression levels of IFNAR and JakSTAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J Virol, 81, 13668-80, 2007.
28. Seng, L. G., J. Daly, K. C. Chang & S. V. Kuchipudi High basal expression of interferon-stimulated genes in human bronchial epithelial (BEAS-2B) cells contributes to influenza A virus resistance. PLoS One, 9, e109023, 2014.
29. Sarasin-Filipowicz, M., E. J. Oakeley, F. H. Duong, V. Christen, L. Terracciano, W. Filipowicz & M. H. Heim Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A, 105, 7034-9, 2008.
30. Dill, M. T., F. H. Duong, J. E. Vogt, S. Bibert, P. Y. Bochud, L. Terracciano, A. Papassotiropoulos, V. Roth & M. H. Heim Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology, 140, 1021-31, 2011.
31. Luszczek, W., V. Cheriyath, T. M. Mekhail & E. C. Borden Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression. Mol Cancer Ther, 9, 2309-21, 2010.
32. Khodarev, N. N., B. Roizman & R. R. Weichselbaum Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growth. Clin Cancer Res, 18, 3015-21, 2012.
33. Lee, Y. A., E. J. Cho & T. Yokozawa Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence. Biol Pharm Bull, 31, 1265-9, 2008.
34. Imai, S. I. & L. Guarente It takes two to tango: NAD(+) and sirtuins in aging/longevity control. NPJ Aging Mech Dis, 2, 16017, 2016.
35. Horinouchi, T., K. Terada, T. Higashi & S. Miwa Using Phos-Tag in Western Blotting Analysis to Evaluate Protein Phosphorylation. Methods Mol Biol, 1397, 267-277, 2016.
36. Epstein, C. J., G. M. Martin, A. L. Schultz & A. G. Motulsky Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore), 45, 177-221, 1966.
37. Furuichi, Y. Premature aging and predisposition to cancers caused by mutations in RecQ family helicases. Ann N Y Acad Sci, 928, 121-31, 2001.
38. Opresko, P. L. Telomere ResQue and preservation--roles for the Werner syndrome protein and other RecQ helicases. Mech Ageing Dev, 129, 79-90, 2008.
39. Campisi, J., J. K. Andersen, P. Kapahi & S. Melov Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol, 21, 354-9, 2011.
40. Childs, B. G., D. J. Baker, J. L. Kirkland, J. Campisi & J. M. van Deursen Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep, 15, 1139-53, 2014.
41. Tchkonia, T. & J. L. Kirkland Aging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies. Jama, 320, 1319-1320, 2018.
42. Franceschi, C. & J. Campisi Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci, 69 Suppl 1, S4-9, 2014.
43. Franceschi, C., M. Capri, D. Monti, S. Giunta, F. Olivieri, F. Sevini, M. P. Panourgia, L. Invidia, L. Celani, M. Scurti, E. Cevenini, G. C. Castellani & S. Salvioli Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev, 128, 92-105, 2007
44. Campisi, J., P. Kapahi, G. J. Lithgow, S. Melov, J. C. Newman & E. Verdin From discoveries in ageing research to therapeutics for healthy ageing. Nature, 571, 183-192, 2019.
45. Zhuang, S. Regulation of STAT signaling by acetylation. Cell Signal, 25, 1924-31, 2013.
46. Chen, K., J. Liu, S. Liu, M. Xia, X. Zhang, D. Han, Y. Jiang, C. Wang & X. Cao Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity. Cell, 170, 492-506.e14, 2017.
47. Yan, S. J., S. J. Lim, S. Shi, P. Dutta & W. X. Li Unphosphorylated STAT and heterochromatin protect genome stability. Faseb j, 25, 232-41, 2011
48. Takahashi, A., T. M. Loo, R. Okada, F. Kamachi, Y. Watanabe, M. Wakita, S. Watanabe, S. Kawamoto, K. Miyata, G. N. Barber, N. Ohtani & E. Hara Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells. Nat Commun, 9, 1249, 2018.
49. De Cecco, M., T. Ito, A. P. Petrashen, A. E. Elias, N. J. Skvir, S. W. Criscione, A. Caligiana, G. Brocculi, E. M. Adney, J. D. Boeke, O. Le, C. Beausejour, J. Ambati, K. Ambati, M. Simon, A. Seluanov, V. Gorbunova, P. E. Slagboom, S. L. Helfand, N. Neretti & J. M. Sedivy L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature, 566, 73-78, 2019.
50. van Deursen, J. M. The role of senescent cells in ageing. Nature, 509, 439-46, 2014.
51. Mikawa, R., Y. Suzuki, H. Baskoro, K. Kanayama, K. Sugimoto, T. Sato & M. Sugimoto Elimination of p19(ARF) -expressing cells protects against pulmonary emphysema in mice. Aging Cell, 17, e12827, 2018.
52. Yosef, R., N. Pilpel, R. Tokarsky-Amiel, A. Biran, Y. Ovadya, S. Cohen, E. Vadai, L. Dassa, E. Shahar, R. Condiotti, I. Ben-Porath & V. Krizhanovsky Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun, 7, 11190, 2016.
53. Schafer, M. J., T. A. White, K. Iijima, A. J. Haak, G. Ligresti, E. J. Atkinson, A. L. Oberg, J. Birch, H. Salmonowicz, Y. Zhu, D. L. Mazula, R. W. Brooks, H. FuhrmannStroissnigg, T. Pirtskhalava, Y. S. Prakash, T. Tchkonia, P. D. Robbins, M. C. Aubry, J. F. Passos, J. L. Kirkland, D. J. Tschumperlin, H. Kita & N. K. LeBrasseur Cellular senescence mediates fibrotic pulmonary disease. Nat Commun, 8, 14532, 2017.
54. Justice, J. N., A. M. Nambiar, T. Tchkonia, N. K. LeBrasseur, R. Pascual, S. K. Hashmi, L. Prata, M. M. Masternak, S. B. Kritchevsky, N. Musi & J. L. Kirkland Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine, 40, 554-563, 2019.
55. Kirkland, J. L., T. Tchkonia, Y. Zhu, L. J. Niedernhofer & P. D. Robbins The Clinical Potential of Senolytic Drugs. J Am Geriatr Soc, 65, 2297-2301, 2017.
56. Lopez-Otin, C., M. A. Blasco, L. Partridge, M. Serrano & G. Kroemer The hallmarks of aging. Cell, 153, 1194-217, 2013.
57. Yamagami, M., M. Otsuka, T. Kishikawa, K. Sekiba, T. Seimiya, E. Tanaka, T. Suzuki, R. Ishibashi, M. Ohno & K. Koike ISGF3 with reduced phosphorylation is associated with constitutive expression of interferon-induced genes in aging cells. NPJ Aging Mech Dis, 4, 11, 2018.